Zobrazeno 1 - 10 of 28 pro vyhledávání: '"Istvan Szipocs"'
1
Incidence rates and disease course of paediatric inflammatory bowel diseases in Western Hungary between 1977 and 2011
Autor: Agnes Horvath, Zsuzsanna Vegh, Laszlo Lakatos, Istvan Szipocs, Katalin Eszter Müller, Tunde Pandur, Gábor Veres, Zsuzsanna Erdelyi, M Mandel, Peter L. Lakatos, Lajos S. Kiss, Barbara D. Lovasz, Petra A. Golovics, Mihaly Balogh
Publikováno v: Digestive and Liver Disease. 46:405-411
Background Limited data are available on paediatric inflammatory bowel diseases in Eastern Europe. Our aim was to analyse disease characteristics in the population-based Veszprem province database between 1977 and 2011. Methods 187 (10.5%, ulcerative
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d088e8c6d0dc37c16b83f5f5d20f1d52
https://doi.org/10.1016/j.dld.2013.12.013
Zobrazit plný text záznamu
2
Is Current Smoking Still an Important Environmental Factor in Inflammatory Bowel Diseases? Results from a Population-based Incident Cohort
Autor: Laszlo Lakatos, Peter L. Lakatos, Mihaly Balogh, Lajos S. Kiss, Istvan Szipocs, C. Molnar, Agnes Horvath, Zsuzsanna Vegh, M Mandel, Zsuzsanna Erdelyi, Barbara D. Lovasz, Miklós Szathmári, Petra A. Golovics, Istvan Szita, Tunde Pandur, Erzsebet Komaromi, Gyula David, Gabor Mester
Publikováno v: Inflammatory Bowel Diseases. 19:1010-1017
BACKGROUND Previous studies suggest that smoking is an important environmental factor in inflammatory bowel diseases (IBDs), with dichotomous effects in ulcerative colitis (UC) and Crohn's disease (CD). The aim of this study was to analyze the relati
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8823a6cf9b2507bdc318bc47aabe6057
https://doi.org/10.1097/mib.0b013e3182802b3e
Zobrazit plný text záznamu
3
Has There Been a Change in the Natural History of Crohn's Disease? Surgical Rates and Medical Management in a Population-Based Inception Cohort from Western Hungary Between 1977–2009
Autor: Erzsebet Komaromi, Peter L. Lakatos, Lajos S. Kiss, Gyula David, Istvan Szipocs, Petra A. Golovics, Zsuzsanna Erdelyi, Laszlo Lakatos, Barbara D. Lovasz, Gábor Veres, C. Molnar, Gabor Mester, Agnes Horvath, Mihaly Balogh, Miklós Szathmári, Tunde Pandur
Publikováno v: American Journal of Gastroenterology. 107:579-588
Medical therapy for Crohn's disease (CD) has changed significantly over the past 20 years with increasing use of immunosuppressives. In contrast, surgery rates are still high and there is little evidence that disease outcomes for CD have changed over
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::474d501dff7772174620923cbd79ecee
https://doi.org/10.1038/ajg.2011.448
Zobrazit plný text záznamu
4
Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: A population-based study from western Hungary 1977–2008
Autor: Istvan Szipocs, Lajos S. Kiss, Gabor Mester, Zsuzsanna Erdelyi, Tunde Pandur, Erzsebet Komaromi, M Balogh, C. Molnar, Peter L. Lakatos, Laszlo Lakatos, Gyula David
Publikováno v: Journal of Crohn's and Colitis. 5:122-128
Limited data are available on the incidence and predictors of colorectal (CRC) and small bowel adenocarcinoma (SBA) in patients with Crohn's disease (CD) from population-based cohorts. Since data are completely missing from Eastern Europe, our aim wa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abf23cd669bc0f7d1e6cd80aa30f1889
https://doi.org/10.1016/j.crohns.2010.11.005
Zobrazit plný text záznamu
8
The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: results from a population-based cohort in Eastern Europe
Autor: Miklós Szathmári, Tunde Pandur, Istvan Szipocs, Lajos S. Kiss, Mihaly Balogh, Agnes Horvath, Erzsebet Komaromi, Petra A. Golovics, Laszlo Lakatos, C. Molnar, Gyula David, Barbara D. Lovasz, Zsuzsanna Erdelyi, M Mandel, Zsuzsanna Vegh, Gabor Mester, Peter L. Lakatos
Publikováno v: Journal of Crohn'scolitis. 7(5)
Background and aims Prior studies suggest a small but significantly increased risk of lymphoma in adults with inflammatory bowel disease (IBD), especially in patients treated with thiopurines. No data was available from Eastern Europe. The aim of thi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3827a256bb75cdbc22d839f70190dac1
https://pubmed.ncbi.nlm.nih.gov/22766526
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje